Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617

In recent years, radiolabeled tracers targeting prostate-specific membrane antigen (PSMA) have had a tremendous impact on prostate cancer management. Here, we report on the formation of radioactive impurities formed during the clinical production of 177Lu-labeled PSMA-617. We provide compelling evid...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2021-04, Vol.64 (8), p.4960-4971
Hauptverfasser: Martin, Sebastian, Tönnesmann, Roswitha, Hierlmeier, Ina, Maus, Stephan, Rosar, Florian, Ruf, Juri, Holland, Jason P, Ezziddin, Samer, Bartholomä, Mark D
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 4971
container_issue 8
container_start_page 4960
container_title Journal of medicinal chemistry
container_volume 64
creator Martin, Sebastian
Tönnesmann, Roswitha
Hierlmeier, Ina
Maus, Stephan
Rosar, Florian
Ruf, Juri
Holland, Jason P
Ezziddin, Samer
Bartholomä, Mark D
description In recent years, radiolabeled tracers targeting prostate-specific membrane antigen (PSMA) have had a tremendous impact on prostate cancer management. Here, we report on the formation of radioactive impurities formed during the clinical production of 177Lu-labeled PSMA-617. We provide compelling evidence that these impurities are the result of a spontaneous, thermally mediated condensation reaction of the Glu-CO-Lys moiety resulting in the formation of three different five-membered ring systems. Density functional theory (DFT) calculations show that the condensation and cyclization of the Glu-CO-Lys moiety is thermodynamically spontaneous. In cell experiments, no affinity of these cyclized compounds toward PSMA was observed. HPLC analyses of urine samples from patient studies showed rapid renal excretion of these radioactive cyclized species. Radiolabeling conditions were identified that significantly reduced the formation of cyclized side products yielding 177Lu-labeled PSMA-617 in high radiochemical yield and purity in concordance with current good manufacturing practice (cGMP) requirements.
doi_str_mv 10.1021/acs.jmedchem.1c00045
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2510247580</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2510247580</sourcerecordid><originalsourceid>FETCH-LOGICAL-a394t-1a440a0e114f7d0af9b3ed07f09cf727930a8381aaa7d49fc74c369026a4005b3</originalsourceid><addsrcrecordid>eNp9kE1PGzEQhq2qqKTAP6iQjxy6Yfyx690jihqIlKpIgRNCq4k_GqNkN9jrQ_j1OE3g2NNIM887Yz-E_GAwZsDZNeo4ftlYo1d2M2YaAGT5hYxYyaGQNcivZATAecErLk7J9xhfMiIYF9_IqRA1rwSHERlmxnaDd17j4PvuJ52sMKAebPBvxw52hi7SdhtsjLlBe0cX3lh6H3qT9BDptA_5HdSk4Lu_dFhZuth1uUQf9_ATU2qenuepuF_8vikqps7JicN1tBfHekYep78eJnfF_M_tbHIzL1A0cigYSgkIljHplAF0zVJYA8pBo53iqhGAtagZIiojG6eV1KJqgFcoAcqlOCNXh73b0L8mG4d246O26zV2tk-x5WU2KVVZQ0blAdWhjzFY126D32DYtQzave82-24_fLdH3zl2ebyQlnn2GfoQnAE4AP_ifQpd_vD_d74Dh4iOow</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2510247580</pqid></control><display><type>article</type><title>Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617</title><source>American Chemical Society Journals</source><creator>Martin, Sebastian ; Tönnesmann, Roswitha ; Hierlmeier, Ina ; Maus, Stephan ; Rosar, Florian ; Ruf, Juri ; Holland, Jason P ; Ezziddin, Samer ; Bartholomä, Mark D</creator><creatorcontrib>Martin, Sebastian ; Tönnesmann, Roswitha ; Hierlmeier, Ina ; Maus, Stephan ; Rosar, Florian ; Ruf, Juri ; Holland, Jason P ; Ezziddin, Samer ; Bartholomä, Mark D</creatorcontrib><description>In recent years, radiolabeled tracers targeting prostate-specific membrane antigen (PSMA) have had a tremendous impact on prostate cancer management. Here, we report on the formation of radioactive impurities formed during the clinical production of 177Lu-labeled PSMA-617. We provide compelling evidence that these impurities are the result of a spontaneous, thermally mediated condensation reaction of the Glu-CO-Lys moiety resulting in the formation of three different five-membered ring systems. Density functional theory (DFT) calculations show that the condensation and cyclization of the Glu-CO-Lys moiety is thermodynamically spontaneous. In cell experiments, no affinity of these cyclized compounds toward PSMA was observed. HPLC analyses of urine samples from patient studies showed rapid renal excretion of these radioactive cyclized species. Radiolabeling conditions were identified that significantly reduced the formation of cyclized side products yielding 177Lu-labeled PSMA-617 in high radiochemical yield and purity in concordance with current good manufacturing practice (cGMP) requirements.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/acs.jmedchem.1c00045</identifier><identifier>PMID: 33826320</identifier><language>eng</language><publisher>United States: American Chemical Society</publisher><ispartof>Journal of medicinal chemistry, 2021-04, Vol.64 (8), p.4960-4971</ispartof><rights>2021 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a394t-1a440a0e114f7d0af9b3ed07f09cf727930a8381aaa7d49fc74c369026a4005b3</citedby><cites>FETCH-LOGICAL-a394t-1a440a0e114f7d0af9b3ed07f09cf727930a8381aaa7d49fc74c369026a4005b3</cites><orcidid>0000-0002-0066-219X ; 0000-0002-0361-2833</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c00045$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/acs.jmedchem.1c00045$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,780,784,2765,27076,27924,27925,56738,56788</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/33826320$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Martin, Sebastian</creatorcontrib><creatorcontrib>Tönnesmann, Roswitha</creatorcontrib><creatorcontrib>Hierlmeier, Ina</creatorcontrib><creatorcontrib>Maus, Stephan</creatorcontrib><creatorcontrib>Rosar, Florian</creatorcontrib><creatorcontrib>Ruf, Juri</creatorcontrib><creatorcontrib>Holland, Jason P</creatorcontrib><creatorcontrib>Ezziddin, Samer</creatorcontrib><creatorcontrib>Bartholomä, Mark D</creatorcontrib><title>Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>In recent years, radiolabeled tracers targeting prostate-specific membrane antigen (PSMA) have had a tremendous impact on prostate cancer management. Here, we report on the formation of radioactive impurities formed during the clinical production of 177Lu-labeled PSMA-617. We provide compelling evidence that these impurities are the result of a spontaneous, thermally mediated condensation reaction of the Glu-CO-Lys moiety resulting in the formation of three different five-membered ring systems. Density functional theory (DFT) calculations show that the condensation and cyclization of the Glu-CO-Lys moiety is thermodynamically spontaneous. In cell experiments, no affinity of these cyclized compounds toward PSMA was observed. HPLC analyses of urine samples from patient studies showed rapid renal excretion of these radioactive cyclized species. Radiolabeling conditions were identified that significantly reduced the formation of cyclized side products yielding 177Lu-labeled PSMA-617 in high radiochemical yield and purity in concordance with current good manufacturing practice (cGMP) requirements.</description><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><recordid>eNp9kE1PGzEQhq2qqKTAP6iQjxy6Yfyx690jihqIlKpIgRNCq4k_GqNkN9jrQ_j1OE3g2NNIM887Yz-E_GAwZsDZNeo4ftlYo1d2M2YaAGT5hYxYyaGQNcivZATAecErLk7J9xhfMiIYF9_IqRA1rwSHERlmxnaDd17j4PvuJ52sMKAebPBvxw52hi7SdhtsjLlBe0cX3lh6H3qT9BDptA_5HdSk4Lu_dFhZuth1uUQf9_ATU2qenuepuF_8vikqps7JicN1tBfHekYep78eJnfF_M_tbHIzL1A0cigYSgkIljHplAF0zVJYA8pBo53iqhGAtagZIiojG6eV1KJqgFcoAcqlOCNXh73b0L8mG4d246O26zV2tk-x5WU2KVVZQ0blAdWhjzFY126D32DYtQzave82-24_fLdH3zl2ebyQlnn2GfoQnAE4AP_ifQpd_vD_d74Dh4iOow</recordid><startdate>20210422</startdate><enddate>20210422</enddate><creator>Martin, Sebastian</creator><creator>Tönnesmann, Roswitha</creator><creator>Hierlmeier, Ina</creator><creator>Maus, Stephan</creator><creator>Rosar, Florian</creator><creator>Ruf, Juri</creator><creator>Holland, Jason P</creator><creator>Ezziddin, Samer</creator><creator>Bartholomä, Mark D</creator><general>American Chemical Society</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-0066-219X</orcidid><orcidid>https://orcid.org/0000-0002-0361-2833</orcidid></search><sort><creationdate>20210422</creationdate><title>Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617</title><author>Martin, Sebastian ; Tönnesmann, Roswitha ; Hierlmeier, Ina ; Maus, Stephan ; Rosar, Florian ; Ruf, Juri ; Holland, Jason P ; Ezziddin, Samer ; Bartholomä, Mark D</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a394t-1a440a0e114f7d0af9b3ed07f09cf727930a8381aaa7d49fc74c369026a4005b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Martin, Sebastian</creatorcontrib><creatorcontrib>Tönnesmann, Roswitha</creatorcontrib><creatorcontrib>Hierlmeier, Ina</creatorcontrib><creatorcontrib>Maus, Stephan</creatorcontrib><creatorcontrib>Rosar, Florian</creatorcontrib><creatorcontrib>Ruf, Juri</creatorcontrib><creatorcontrib>Holland, Jason P</creatorcontrib><creatorcontrib>Ezziddin, Samer</creatorcontrib><creatorcontrib>Bartholomä, Mark D</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Martin, Sebastian</au><au>Tönnesmann, Roswitha</au><au>Hierlmeier, Ina</au><au>Maus, Stephan</au><au>Rosar, Florian</au><au>Ruf, Juri</au><au>Holland, Jason P</au><au>Ezziddin, Samer</au><au>Bartholomä, Mark D</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2021-04-22</date><risdate>2021</risdate><volume>64</volume><issue>8</issue><spage>4960</spage><epage>4971</epage><pages>4960-4971</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><abstract>In recent years, radiolabeled tracers targeting prostate-specific membrane antigen (PSMA) have had a tremendous impact on prostate cancer management. Here, we report on the formation of radioactive impurities formed during the clinical production of 177Lu-labeled PSMA-617. We provide compelling evidence that these impurities are the result of a spontaneous, thermally mediated condensation reaction of the Glu-CO-Lys moiety resulting in the formation of three different five-membered ring systems. Density functional theory (DFT) calculations show that the condensation and cyclization of the Glu-CO-Lys moiety is thermodynamically spontaneous. In cell experiments, no affinity of these cyclized compounds toward PSMA was observed. HPLC analyses of urine samples from patient studies showed rapid renal excretion of these radioactive cyclized species. Radiolabeling conditions were identified that significantly reduced the formation of cyclized side products yielding 177Lu-labeled PSMA-617 in high radiochemical yield and purity in concordance with current good manufacturing practice (cGMP) requirements.</abstract><cop>United States</cop><pub>American Chemical Society</pub><pmid>33826320</pmid><doi>10.1021/acs.jmedchem.1c00045</doi><tpages>12</tpages><orcidid>https://orcid.org/0000-0002-0066-219X</orcidid><orcidid>https://orcid.org/0000-0002-0361-2833</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2021-04, Vol.64 (8), p.4960-4971
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_2510247580
source American Chemical Society Journals
title Identification, Characterization, and Suppression of Side Products Formed during the Synthesis of [177Lu]Lu-PSMA-617
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-02T18%3A14%3A52IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Identification,%20Characterization,%20and%20Suppression%20of%20Side%20Products%20Formed%20during%20the%20Synthesis%20of%20%5B177Lu%5DLu-PSMA-617&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Martin,%20Sebastian&rft.date=2021-04-22&rft.volume=64&rft.issue=8&rft.spage=4960&rft.epage=4971&rft.pages=4960-4971&rft.issn=0022-2623&rft.eissn=1520-4804&rft_id=info:doi/10.1021/acs.jmedchem.1c00045&rft_dat=%3Cproquest_cross%3E2510247580%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2510247580&rft_id=info:pmid/33826320&rfr_iscdi=true